Abstract The United States Food and Drug Administration (US FDA) has always been a
forerunner in drug evaluation and supervision. Over the past 31 years, 1050 drugs …

The treatment of advanced thyroid cancer has undergone rapid evolution in the last decade,
with multiple kinase inhibitor drug approvals for each subtype of thyroid cancer and a …

Importance Thyroid cancer is the most pervasive endocrine cancer worldwide. Studies
examining the association between thyroid cancer and country, sex, age, sociodemographic …

Abstract Background N6-methyladenosine (m6A) modification is the most common chemical
modification in mammalian mRNAs, and it plays important roles by regulating several …

Background: Active surveillance has been proposed as an appropriate management
strategy for low-risk differentiated thyroid cancer (DTC), due to the typically favorable …

Thyroid nodule is one of the common life-threatening diseases, and it had an increasing
trend over the last years. Ultrasound imaging is a commonly used diagnostic method for …

Background Despite rising incidence and mortality rates in Africa, cancer has been given
low priority in the research field and in healthcare services. Indeed, 57% of all new cancer …

Population-based studies have demonstrated that an increasing number of incidental
thyroid nodules are being identified. The corresponding increase in thyroid-based …

Growing evidence indicates that N6-methyladenosine (m 6 A) is the most pervasive RNA
modification in eukaryotic cells. However, the specific role of METTL3 in papillary thyroid …

In the past decade, a growing body of literature has reported promising results for prostate-
specific membrane antigen (PSMA)-targeted radionuclide imaging and therapy in prostate …